BiomedicalPublications

Molecular Therapy — Nucleic Acids

Cell Press·United States·ISSN 2162-2531

Open accessIn DOAJFee waivers availableBiochemistry, Genetics and Molecular Biology

Cost to publish

$3,900

Open-access article processing charge, list price.

Time to publication

23 wks

Slower than average; plan your timeline accordingly.

h-index

131

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

4.9

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Molecular Therapy — Nucleic Acids is listed at $3,900. The publisher also lists 3,610 EUR, 3,120 GBP, 483,720 JPY. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Molecular Therapy — Nucleic Acids, as recorded by OpenAlex for each year. The fee has risen 11% since 2019, from $3,500 to $3,900.

$0$2k$3.9k2019: $3,50020192020: $3,50020202021: $3,90020212022: $3,90020222023: $3,90020232024: $3,90020242025: $3,9002025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY, CC BY-NC, CC BY-NC-ND
Author keeps copyrightNo
Plagiarism screeningNot reported
Editorial boardPublished →
LanguagesEN

Verification checks

7 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects Molecular Therapy — Nucleic Acids publishes most, derived from the topics assigned to its indexed articles.

RNA Interference and Gene DeliveryMicroRNA in disease regulationCancer-related molecular mechanisms researchCRISPR and Genetic EngineeringCircular RNAs in diseasesAdvanced biosensing and bioanalysis techniquesRNA modifications and cancerRNA Research and SplicingVirus-based gene therapy researchRNA and protein synthesis mechanisms

Publication record

Indexed articles3,388
Total citations119,094
i10-index2,232
Most recent indexed article2026
Open access since2012
All ISSNs2162-2531

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.